Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Advanced Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01432951
What this trial is testing

Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma

Who this might be right for
Solid TumorLymphoma, Malignant
Eli Lilly and Company 26
Early research (Phase 1)Study completedNCT02106845
What this trial is testing

Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.

Who this might be right for
Neoplasms
Bayer 42
Early research (Phase 1)Active Not RecruitingNCT02453620
What this trial is testing

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+2 more
National Cancer Institute (NCI) 57
Early research (Phase 1)UnknownNCT05819684
What this trial is testing

SHR-4602 in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumor
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 133
Very early researchNot Yet RecruitingNCT06713148
What this trial is testing

Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Fudan University 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03830918
What this trial is testing

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

Who this might be right for
Advanced Malignant Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
Jonsson Comprehensive Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT00445458
What this trial is testing

HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer

Who this might be right for
Advanced Breast CancerAdvanced Malignant Solid TumorsBreast Neoplasms
Puma Biotechnology, Inc. 110
Early research (Phase 1)Looking for participantsNCT07274085
What this trial is testing

HDM2017 in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 96
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Not applicableUnknownNCT06512896
What this trial is testing

Clinical Study on Intraluminal Injection of FOLactis

Who this might be right for
Solid TumorImmune ResponsePleural Effusion, Malignant+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272590
What this trial is testing

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Qilu Pharmaceutical Co., Ltd. 290
Early research (Phase 1)Study completedNCT02675491
What this trial is testing

Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Advanced Solid Malignant Tumors
Daiichi Sankyo Co., Ltd. 15
Early research (Phase 1)Ended earlyNCT01243762
What this trial is testing

Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Who this might be right for
Neoplasms Malignant
Merck Sharp & Dohme LLC 47
Early research (Phase 1)Study completedNCT04126668
What this trial is testing

Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

Who this might be right for
Advanced Malignant Solid Tumors
AnewPharma 24
Testing effectiveness (Phase 2)Looking for participantsNCT07326488
What this trial is testing

MHB009C in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd 200
Early research (Phase 1)Looking for participantsNCT06821048
What this trial is testing

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerStomach CancerPancreatic Cancer+1 more
Weijia Fang, MD 18
Early research (Phase 1)UnknownNCT04275050
What this trial is testing

Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets

Who this might be right for
Advanced Malignant Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 40
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT01648764
What this trial is testing

LY2334737 in Participants With Cancer That is Advanced and/or Has Spread

Who this might be right for
Malignant Solid TumorSolid TumorMetastatic Tumor
Eli Lilly and Company 73
Early research (Phase 1)UnknownNCT05499715
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Advanced Tumor of Digestive Tract or Urinary System
Chinese Academy of Medical Sciences 48
Next Page